The results from the Cox regression analysis demonstrated that an elevated expression of SMURF2 had a negative correlation with the survival time of patients with pancreatic cancer (Figure 1), which is of great importance for predicting patient survival. This evidence concerns the gene SMURF2 and familial pancreatic carcinoma.